GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Total Stockholders Equity

Accustem Sciences (Accustem Sciences) Total Stockholders Equity : $-2.62 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences Total Stockholders Equity?

Accustem Sciences's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-2.62 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Accustem Sciences's Book Value per Share for the quarter that ended in Mar. 2024 was $-0.23. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Accustem Sciences's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Accustem Sciences Total Stockholders Equity Historical Data

The historical data trend for Accustem Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences Total Stockholders Equity Chart

Accustem Sciences Annual Data
Trend Dec22 Dec23
Total Stockholders Equity
-0.14 -2.11

Accustem Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only -0.95 -1.31 -1.89 -2.11 -2.62

Accustem Sciences  (OTCPK:ACUT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Accustem Sciences's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-2.62-0)/11.3465
=-0.23

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Accustem Sciences's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / -2.62
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accustem Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Accustem Sciences (Accustem Sciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Total Stockholders Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001
Website
http://www.accustem.com
Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.